Global Blood Ther (NQ: GBT )

39.96 USD -1.00 (-2.44%)

Streaming Delayed Price Updated: 1:41 PM EST, Mar 8, 2021 Add to My Watchlist

Price and Volume

Volume	460,353
Open	41.19
Bid (Size)	39.93 (1)
Ask (Size)	40.01 (3)
Prev. Close	40.96
Today's Range	39.38 - 41.25
52wk Range	36.49 - 83.69
Shares Outstanding	51,825,849
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

GBT Announces New Employment Inducement Grants

Today 8:00 EST

GBT Opens 2021 ACCEL Grant Program, Providing up to $500,000 in Support to the Sickle Cell Disease Community

March 02, 2021

Grant proposals from community-based organizations and institutions accepted through April 23, 2021

Performance

YTD	-9.72%	-9.72%
1 Month	-21.35%	-21.35%
3 Month	-3.36%	-3.36%
6 Month	-31.97%	-31.97%
1 Year	-34.77%	-34.77%

More News

GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference

March 02, 2021

GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results

February 24, 2021

GBT Announces Participation in Upcoming Investor Conferences

February 19, 2021

GBT to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021

February 17, 2021

GBT Announces New Employment Inducement Grants

February 05, 2021

GBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States

February 04, 2021

European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell Disease

January 27, 2021

Recap: Global Blood Therapeutics Q4 Earnings

February 24, 2021

Preview: Global Blood Therapeutics's Earnings

February 23, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.